Patient-specific neutralizing antibody responses to herpes simplex virus are attributed to epitopes on gD, gB, or both and can be type specific

Journal of Virology

Volumn 89, Issue 18, 2015, Pages 9213-9231

  Cairns, Tina M ^a   Huang, Zhen Yu ^a   Gallagher, John R ^b   Lin, Yixin ^c   Lou, Huan ^a   Whitbeck, J Charles ^a   Wald, Anna ^d   Cohen, Gary H ^a   Eisenberg, Roselyn J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c Pall ForteBio Corporation   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR BINDING GLYCOPROTEIN B MONOCLONAL ANTIBODY; CELL RECEPTOR BINDING GLYCOPROTEIN D MONOCLONAL ANTIBODY; EPITOPE; GLYCOPROTEIN; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ANIMAL CELL; ANTIBODY RESPONSE; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; BIOTINYLATION; BLOOD SAMPLING; GENITAL HERPES; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RECEPTOR BINDING; RECURRENT INFECTION; SEROTYPE; VIRUS ENTRY; VIRUS NEUTRALIZATION; VIRUS TITRATION; ANIMAL; ANTIBODY SPECIFICITY; CHEMISTRY; CHLOROCEBUS AETHIOPS; CROSS REACTION; IMMUNOLOGY; MOUSE; VERO CELL LINE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; CERCOPITHECUS AETHIOPS; CROSS REACTIONS; EPITOPES; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; IMMUNOGLOBULIN G; MICE; VERO CELLS;

EID: 84940468565     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01213-15     Document Type: Article

References (63)

1. Grinde B. 2013. Herpesviruses: latency and reactivation-viral strategies and host response. J Oral Microbiol 2013:5. http://dx.doi.org/10.3402 /jom.v5i0.22766.
2. Whitley RJ. 1993. Neonatal herpes simplex virus infections. J Med Virol Suppl 1:13-21.
3. Bradley H, Markowitz LE, Gibson T, McQuillan GM. 2014. Seroprevalence of herpes simplex virus types 1 and 2: United States, 1999-2010. J Infect Dis 209:325-333. http://dx.doi.org/10.1093/infdis/jit458.
4. Sacks SL, Griffiths PD, Corey L, Cohen C, Cunningham A, Dusheiko GM, Self S, Spruance S, Stanberry LR, Wald A, Whitley RJ. 2004. HSV shedding. Antivir Res 63(Suppl 1):S19 -S26.
5. Tronstein E, Johnston C, Huang ML, Selke S, Magaret A, Warren T, Corey L, Wald A. 2011. Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection. JAMA 305:1441-1449. http://dx.doi.org/10.1001/jama.2011.420.
6. Schiffer JT. 2013. Mucosal HSV-2 specific CD8± T cells represent containment of prior viral shedding rather than a correlate of future protection. Front Immunol 4:209. http://dx.doi.org/10.3389/fimmu.2013.00209.
7. Belshe RB, Heineman TC, Bernstein DI, Bellamy AR, Ewell M, van der Most R, Deal CD. 2014. Correlate of immune protection against HSV-1 genital disease in vaccinated women. J Infect Dis 209:828-836. http://dx .doi.org/10.1093/infdis/jit651.
8. Awasthi S, Friedman HM. 2014. A paradigm shift: vaccine-induced antibodies as an immune correlate of protection against herpes simplex virus type 1 genital herpes. J Infect Dis 209:813-815. http://dx.doi.org/10.1093 /infdis/jit658.
9. Eisenberg RJ, Atanasiu D, Cairns TM, Gallagher JR, Krummenacher C, Cohen GH. 2012. Herpesvirus fusion and entry: a story with many characters. Viruses 4:800-832. http://dx.doi.org/10.3390/v4050800.
10. Bender FC, Samanta M, Heldwein EE, de Leon MP, Bilman E, Lou H, Whitbeck JC, Eisenberg RJ, Cohen GH. 2007. Antigenic and mutational analyses of herpes simplex virus glycoprotein B reveal four functional regions. J Virol 81:3827-3841. http://dx.doi.org/10.1128/JVI.02710-06.
11. Whitbeck JC, Muggeridge MI, Rux AH, Hou W, Krummenacher C, Lou H, van Geelen A, Eisenberg RJ, Cohen GH. 1999. The major neutralizing antigenic site on herpes simplex virus glycoprotein D overlaps a receptorbinding domain. J Virol 73:9879-9890.
12. Cairns TM, Shaner MS, Zuo Y, Ponce-de-Leon M, Baribaud I, Eisenberg RJ, Cohen GH, Whitbeck JC. 2006. Epitope mapping of herpes simplex virus type 2 gH/gL defines distinct antigenic sites, including some associated with biological function. J Virol 80:2596-2608. http://dx.doi .org/10.1128/JVI.80.6.2596-2608.2006.
13. Peng T, Ponce-de-Leon M, Jiang H, Dubin G, Lubinski JM, Eisenberg RJ, Cohen GH. 1998. The gH-gL complex of herpes simplex virus (HSV) stimulates neutralizing antibody and protects mice against HSV type 1 challenge. J Virol 72:65-72.
14. Nicola AV, Ponce de Leon M, Xu R, Hou W, Whitbeck JC, Krummenacher C, Montgomery RI, Spear PG, Eisenberg RJ, Cohen GH. 1998. Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM. J Virol 72:3595-3601.
15. Atanasiu D, Saw WT, Cohen GH, Eisenberg RJ. 2010. Cascade of events governing cell-cell fusion induced by herpes simplex virus glycoproteins gD, gH/gL, and gB. J Virol 84:12292-12299. http://dx.doi.org/10.1128/JVI .01700-10.
16. Chowdary TK, Cairns TM, Atanasiu D, Cohen GH, Eisenberg RJ, Heldwein EE. 2010. Crystal structure of the conserved herpesvirus fusion regulator complex gH-gL. Nat Struct Mol Biol 17:882-888. http://dx.doi .org/10.1038/nsmb.1837.
17. Heldwein EE, Lou H, Bender FC, Cohen GH, Eisenberg RJ, Harrison SC. 2006. Crystal structure of glycoprotein B from herpes simplex virus 1. Science 313:217-220. http://dx.doi.org/10.1126/science.1126548.
18. Backovic M, DuBois RM, Cockburn JJ, Sharff AJ, Vaney MC, Granzow H, Klupp BG, Bricogne G, Mettenleiter TC, Rey FA. 2010. Structure of a core fragment of glycoprotein H from pseudorabies virus in complex with antibody. Proc Natl Acad Sci U S A 107:22635-22640. http://dx.doi .org/10.1073/pnas.1011507107.
19. Backovic M, Longnecker R, Jardetzky TS. 2009. Structure of a trimeric variant of the Epstein-Barr virus glycoprotein B. Proc Natl Acad Sci U S A 106:2880-2885. http://dx.doi.org/10.1073/pnas.0810530106.
20. Matsuura H, Kirschner AN, Longnecker R, Jardetzky TS. 2010. Crystal structure of the Epstein-Barr virus (EBV) glycoprotein H/glycoprotein L (gH/gL) complex. Proc Natl Acad Sci U S A 107:22641-22646. http://dx .doi.org/10.1073/pnas.1011806108.
21. Ciferri C, Chandramouli S, Donnarumma D, Nikitin PA, Cianfrocco MA, Gerrein R, Feire AL, Barnett SW, Lilja AE, Rappuoli R, Norais N, Settembre EC, Carfi A. 2015. Structural and biochemical studies of hCMV gH/gL/gO and pentamer reveal mutually exclusive cell entry complexes. Proc Natl Acad Sci U S A 112:1767-1772. http://dx.doi.org/10 .1073/pnas.1424818112.
22. Atanasiu D, Whitbeck JC, Cairns TM, Reilly B, Cohen GH, Eisenberg RJ. 2007. Bimolecular complementation reveals that glycoproteins gB and gH/gL of herpes simplex virus interact with each other during cell fusion. Proc Natl Acad Sci U S A 104:18718-18723. http://dx.doi.org/10.1073 /pnas.0707452104.
23. Svennerholm B, Jeansson S, Vahlne A, Lycke E. 1991. Involvement of glycoprotein C (gC) in adsorption of herpes simplex virus type 1 (HSV-1) to the cell. Arch Virol 120:273-279. http://dx.doi.org/10.1007 /BF01310482.
24. Rux AH, Lou H, Lambris JD, Friedman HM, Eisenberg RJ, Cohen GH. 2002. Kinetic analysis of glycoproteinCof herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b. Virology 294:324-332. http://dx.doi.org/10.1006/viro.2001.1326.
25. Awasthi S, Lubinski JM, Shaw CE, Barrett SM, Cai M, Wang F, Betts M, Kingsley S, Distefano DJ, Balliet JW, Flynn JA, Casimiro DR, Bryan JT, Friedman HM. 2011. Immunization with a vaccine combining herpes simplex virus 2 (HSV-2) glycoprotein C (gC) and gD subunits improves the protection of dorsal root ganglia in mice and reduces the frequency of recurrent vaginal shedding of HSV-2 DNA in guinea pigs compared to immunization with gD alone. J Virol 85:10472-10486. http://dx.doi.org /10.1128/JVI.00849-11.
26. Weir JP, Bennett M, Allen EM, Elkins KL, Martin S, Rouse BT. 1989. Recombinant vaccinia virus expressing the herpes simplex virus type 1 glycoprotein C protects mice against herpes simplex virus challenge. J Gen Virol 70(Pt 10):2587-2594.
27. Awasthi S, Balliet JW, Flynn JA, Lubinski JM, Shaw CE, DiStefano DJ, Cai M, Brown M, Smith JF, Kowalski R, Swoyer R, Galli J, Copeland V, Rios S, Davidson RC, Salnikova M, Kingsley S, Bryan J, Casimiro DR, Friedman HM. 2014. Protection provided by a herpes simplex virus 2 (HSV-2) glycoprotein C and D subunit antigen vaccine against genital HSV-2 infection in HSV-1-seropositive guinea pigs. J Virol 88:2000-2010. http://dx.doi.org/10.1128/JVI.03163-13.
28. Eing BR, Kuhn JE, Braun RW. 1989. Neutralizing activity of antibodies against the major herpes simplex virus type 1 glycoproteins. J Med Virol 27:59-65. http://dx.doi.org/10.1002/jmv.1890270113.
29. Muggeridge MI, Isola VJ, Byrn RA, Tucker TJ, Minson AC, Glorioso JC, Cohen GH, Eisenberg RJ. 1988. Antigenic analysis of a major neutralization site of herpes simplex virus glycoprotein D using deletion mutants and monoclonal antibody-resistant mutants. J Virol 62:3274-3280.
30. Friedman HM. 2003. Immune evasion by herpes simplex virus type 1, strategies for virus survival. Trans Am Clin Climatol Assoc 114:103-112.
31. Hook LM, Huang J, Jiang M, Hodinka R, Friedman HM. 2008. Blocking antibody access to neutralizing domains on glycoproteins involved in entry as a novel mechanism of immune evasion by herpes simplex virus type 1 glycoproteins C and E. J Virol 82:6935-6941. http://dx.doi.org/10.1128 /JVI.02599-07.
32. Belshe RB, Leone PA, Bernstein DI, Wald A, Levin MJ, Stapleton JT, Gorfinkel I, Morrow RL, Ewell MG, Stokes-Riner A, Dubin G, Heineman TC, Schulte JM, Deal CD. 2012. Efficacy results of a trial of a herpes simplex vaccine. N Engl J Med 366:34-43. http://dx.doi.org/10.1056 /NEJMoa1103151.
33. Awasthi S, Belshe RB, Friedman HM. 2014. Better neutralization of herpes simplex virus type 1 (HSV-1) than HSV-2 by antibody from recipients of GlaxoSmithKline HSV-2 glycoprotein D2 subunit vaccine. J Infect Dis 210:571-575. http://dx.doi.org/10.1093/infdis/jiu177.
34. Whitbeck JC, Huang ZY, Cairns TM, Gallagher JR, Lou H, Ponce-de-Leon M, Belshe RB, Eisenberg RJ, Cohen GH. 2014. Repertoire of epitopes recognized by serum IgG from humans vaccinated with herpes simplex virus 2 glycoprotein D. J Virol 88:7786-7795. http://dx.doi.org /10.1128/JVI.00544-14.
35. Cairns TM, Huang ZY, Whitbeck JC, Ponce de Leon M, Lou H, Wald A, Krummenacher C, Eisenberg RJ, Cohen GH. 2014. Dissection of the antibody response against herpes simplex virus glycoproteins in naturally infected humans. J Virol 88:12612-12622. http://dx.doi.org/10.1128/JVI .01930-14.
36. Lazear E, Whitbeck JC, Ponce-de-Leon M, Cairns TM, Willis SH, Zuo Y, Krummenacher C, Cohen GH, Eisenberg RJ. 2012. Antibody-induced conformational changes in herpes simplex virus glycoprotein gD reveal new targets for virus neutralization. J Virol 86:1563-1576. http://dx.doi .org/10.1128/JVI.06480-11.
37. Muggeridge MI, Wu T-T, Johnson DC, Glorioso JC, Eisenberg RJ, Cohen GH. 1990. Antigenic and functional analysis of a neutralization site of HSV-1 glycoprotein D. Virology 174:375-387. http://dx.doi.org/10 .1016/0042-6822(90)90091-5.
38. Cairns TM, Fontana J, Huang ZY, Whitbeck JC, Atanasiu D, Rao S, Shelly SS, Lou H, Ponce de Leon M, Steven AC, Eisenberg RJ, Cohen GH. 2014. Mechanism of neutralization of herpes simplex virus by antibodies directed at the fusion domain of glycoprotein B. J Virol 88:2677-2689. http://dx.doi.org/10.1128/JVI.03200-13.
39. Tal-Singer R, Peng C, Ponce De Leon M, Abrams WR, Banfield BW, Tufaro F, Cohen GH, Eisenberg RJ. 1995. Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules. J Virol 69:4471-4483.
40. Cairns TM, Whitbeck JC, Lou H, Heldwein EE, Chowdary TK, Eisenberg RJ, Cohen GH. 2011. Capturing the herpes simplex virus core fusion complex (gB-gH/gL) in an acidic environment. J Virol 85:6175-6184. http://dx.doi.org/10.1128/JVI.00119-11.
41. Bender FC, Whitbeck JC, Ponce de Leon M, Lou H, Eisenberg RJ, Cohen GH. 2003. Specific association of glycoprotein B with lipid rafts during herpes simplex virus entry. J Virol 77:9542-9552. http://dx.doi.org /10.1128/JVI.77.17.9542-9552.2003.
42. Hannah BP, Cairns TM, Bender FC, Whitbeck JC, Lou H, Eisenberg RJ, Cohen GH. 2009. Herpes simplex virus glycoprotein B associates with target membranes via its fusion loops. J Virol 83:6825-6836. http://dx.doi .org/10.1128/JVI.00301-09.
43. Cohen GH, Isola VJ, Kuhns J, Berman PW, Eisenberg RJ. 1986. Localization of discontinuous epitopes of herpes simplex virus glycoprotein D: use of a nondenaturing ("native" gel) system of polyacrylamide gel electrophoresis coupled with Western blotting. J Virol 60:157-166.
44. Eisenberg RJ, Long D, Ponce de Leon M, Matthews JT, Spear PG, Gibson MG, Lasky LA, Berman P, Golub E, Cohen GH. 1985. Localization of epitopes of herpes simplex virus type 1 glycoprotein D. J Virol 53:634-644.
45. Concepcion J, Witte K, Wartchow C, Choo S, Yao D, Persson H, Wei J, Li P, Heidecker B, Ma W, Varma R, Zhao LS, Perillat D, Carricato G, Recknor M, Du K, Ho H, Ellis T, Gamez J, Howes M, Phi-Wilson J, Lockard S, Zuk R, Tan H. 2009. Label-free detection of biomolecular interactions using biolayer interferometry for kinetic characterization. Comb Chem High Throughput Screen 12:791-800.
46. Markowski CA, Markowski EP. 1990. Conditions for the effectiveness of a preliminary test of variance. Am Statistician 44:322-326. http://dx.doi .org/10.1080/00031305.1990.10475752.
47. Hollander M, Wolfe DA. 1973. Nonparametric statistical methods, p 68-75. John Wiley & Sons, Inc, New York, NY.
48. Royston P. 1982. An extension of Shapiro and Wilk'sWtest for normality to large samples. Appl Stat 31:115-124. http://dx.doi.org/10.2307 /2347973.
49. Core Team R. 2013. R: a language and environment for statistical computing. R-Project, Vienna, Austria. http://www.R-project.org.
50. Atanasiu D, Whitbeck JC, de Leon MP, Lou H, Hannah BP, Cohen GH, Eisenberg RJ. 2010. Bimolecular complementation defines functional regions of herpes simplex virus gB that are involved with gH/gL as a necessary step leading to cell fusion. J Virol 84:3825-3834. http://dx.doi.org/10 .1128/JVI.02687-09.
51. Hannah BP, Heldwein EE, Bender FC, Cohen GH, Eisenberg RJ. 2007. Mutational evidence of internal fusion loops in herpes simplex virus glycoprotein B. J Virol 81:4858 - 4865. http://dx.doi.org/10.1128/JVI.02755-06.
52. Bender FC, Whitbeck JC, Lou H, Cohen GH, Eisenberg RJ. 2005. Herpes simplex virus glycoprotein B binds to cell surfaces independently of heparan sulfate and blocks virus entry. J Virol 79:11588-11597. http: //dx.doi.org/10.1128/JVI.79.18.11588-11597.2005.
53. Nelson MH, Bird MD, Chu CF, Johnson AJ, Friedrich BM, Allman WR, Milligan GN. 2011. Rapid clearance of herpes simplex virus type 2 by CD8± T cells requires high level expression of effector T cell functions. J Reprod Immunol 89:10-17. http://dx.doi.org/10.1016/j.jri.2011.01.013.
54. Khan AA, Srivastava R, Spencer D, Garg S, Fremgen D, Vahed H, Lopes PP, Pham TT, Hewett C, Kuang J, Ong N, Huang L, Scarfone VM, Nesburn AB, Wechsler SL, BenMohamed L. 2015. Phenotypic and functional characterization of herpes simplex virus glycoprotein B epitopespecific effector and memory CD8± T cells from symptomatic and asymptomatic individuals with ocular herpes. J Virol 89:3776-3792. http://dx .doi.org/10.1128/JVI.03419-14.
55. Li J, Schantz A, Schwegler M, Shankar G. 2011. Detection of low-affinity anti-drug antibodies and improved drug tolerance in immunogenicity testing by Octet(R) biolayer interferometry. J Pharm Biomed Anal 54: 286-294. http://dx.doi.org/10.1016/j.jpba.2010.08.022.
56. Vratskikh O, Stiasny K, Zlatkovic J, Tsouchnikas G, Jarmer J, Karrer U, Roggendorf M, Roggendorf H, Allwinn R, Heinz FX. 2013. Dissection of antibody specificities induced by yellow fever vaccination. PLoS Pathog 9:e1003458. http://dx.doi.org/10.1371/journal.ppat.1003458.
57. Jarmer J, Zlatkovic J, Tsouchnikas G, Vratskikh O, Strauss J, Aberle JH, Chmelik V, Kundi M, Stiasny K, Heinz FX. 2014. Variation of the specificity of the human antibody responses after tick-borne encephalitis virus infection and vaccination. J Virol 88:13845-13857. http://dx.doi.org /10.1128/JVI.02086-14.
58. Di Giovine P, Settembre EC, Bhargava AK, Luftig MA, Lou H, Cohen GH, Eisenberg RJ, Krummenacher C, Carfi A. 2011. Structure of herpes simplex virus glycoproteinDbound to the human receptor nectin-1. PLoS Pathog 7:e1002277. http://dx.doi.org/10.1371/journal.ppat.1002277.
59. Connolly SA, Landsburg DJ, Carfi A, Wiley DC, Cohen GH, Eisenberg RJ. 2003. Structure-based mutagenesis of herpes simplex virus glycoproteinDdefines three critical regions at the gD-HveA/HVEM binding interface. J Virol 77:8127-8140. http://dx.doi.org/10.1128/JVI.77.14.8127 -8140.2003.
60. Warner MS, Geraghty RJ, Martinez WM, Montgomery RI, Whitbeck JC, Xu R, Eisenberg RJ, Cohen GH, Spear PG. 1998. A cell surface protein with herpesvirus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus. Virology 246:179-189. http://dx.doi.org /10.1006/viro.1998.9218.
61. Lazear E, Carfi A, Whitbeck JC, Cairns TM, Krummenacher C, Cohen GH, Eisenberg RJ. 2008. Engineered disulfide bonds in herpes simplex virus type 1 gD separate receptor binding from fusion initiation and viral entry. J Virol 82:700-709. http://dx.doi.org/10.1128/JVI.02192-07.
62. Schiffer JT, Corey L. 2009. New concepts in understanding genital herpes. Curr Infect Dis Rep 11:457-464. http://dx.doi.org/10.1007/s11908 -009-0066-7.
63. Ashley RL, Militoni J, Lee F, Nahmias A, Corey L. 1988. Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol 26:662-667.